Cancer Vaccines Market 2021 | Outlook, Growth By Top Companies, Regions, Types, Applications, Drivers, Trends & Forecasts by 2030
Cancer
Vaccines Market size is expected to portray promising scenarios, as it is
estimated to reach $12.64 billion in 2030 which was initially valued at around
$4.95 billion in 2021, thereby registering a CAGR of nearly 9.8% from 2022 to
2030. Cancer vaccines are biological response modifiers that stimulate the
immune system of the body to fight against cancer.
To Enquiry before Buy this Research Report or For
Any Customization Ask: https://www.decisionforesight.com/inquire/DFS023410
MARKET DYNAMICS AND FACTORS
the cancer
vaccines market is driven by several factors such as increase in the number of
cancer patients due to unhealthy and harmful lifestyle practices (e.g., smoking
and use of tobacco in other forms), funding by government and commercial
enterprises to carry out research and development in the field of cancer
vaccine development, rise in the geriatric population and increasing
expenditure by people for healthcare services. However, higher costs and long
timespan associated with cancer vaccine production by the manufacturers are the
challenges in the path of cancer vaccine market growth.
MARKET SEGMENTATION
Like several other
industries, the cancer vaccines market is also segmented in the following way-
·
On
basis of Product Type – Preventive and Therapeutic
·
On
basis of Application – Cervical Cancer, Prostate Cancer, and Others
·
On
basis of Technology - Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines,
Antigen/Adjuvant Cancer Vaccines, Viral Vector and DNA Cancer Vaccines
·
On
basis of End User - Pediatrics and Adults
·
By
Geography – North America, Asia Pacific, Middle east and Africa, Latin America,
Europe.
GEOGRAPHIC ANALYSIS
North America
occupies the largest share in the cancer vaccine market due to high level of
overall developmental activities prevalent in the region. Asia Pacific is
anticipated to offer lucrative growth opportunities due to higher population
and patient base in the emergent economies where technological advancements and
establishment of medical centers is taking place gradually.
Directly Purchase this Market Research Report Now
@ https://www.decisionforesight.com/checkout/DFS023410
COMPETITIVE ANALYSIS
The cancer vaccines market portrays a
competitive landscape with various international and regional/local players
trying to rise above each other. All of them aim at providing high efficacy
rates along with novel vaccine production. Some of the key players in the
cancer vaccine market are –BioNTech, GlaxoSmithKline, Modern, CureVac, Anixa
Bioscience, Elios Therapeutics, Amgen Inc., Dendreon Corp., F. Hoffmann-La Roche
Ltd., Merck & Co. Inc., Vaccinogen
Inc.
KEY MARKET PLAYERS
§
BioNTech
§
GlaxoSmithKline
§
Modern,
§
CureVac
§
Anixa
Bioscience
§
Elios
Therapeutics
§
Amgen
Inc.
§
Dendreon
Corp.
§
F.
Hoffmann-La Roche Ltd.
§
Merck
& Co. Inc.
§
Vaccinogen Inc.
About Us:
Decision Foresight is a market research organization known for its reliable and
genuine content, market estimation and the best analysis which is designed to
deliver state-of-the-art quality syndicate reports to our customers. Apart from
syndicate reports, you will find the best market insights, strategies that will
help in taking better business decisions on subjects that may require you to
develop and grow your business-like health, science, technology and many more.
At Decision Foresight, we truly believe in disseminating the right piece of
knowledge to a large section of the audience and cover the in-depth insights of
market leaders across various verticals and horizontals.
Contact Us: 125, Beadon Street, Kolkata -700006
Phone: +919875577841
Email: sales@decisionforesight.com

Comments
Post a Comment